DNER and melanoma: To further clarify the underlying mechanism of the synergy induced by combination treatment with BET inhibitors and sunitinib, we performed RNA-seq analysis on the following groups of A375 melanoma cells treated for 24 h as indicated: control; JQ1, 1 μM; sunitinib, 4 μM; combination, JQ1, 1 μM and sunitinib, 4 μM.